Abstract. Improved enzyme immunoassay (EIA) procedures achieved by incorporating sodium azide during predilution of serum samples in a solid-phase EIA for the detection of anti-Toxoplasma antibody in swine using a peroxidase conjugate and in all washes of a bovine brucellosis rapid card test EIA using alkaline phosphatase conjugate are reported. Without this modification, substantial background interference was encountered that showed direct correlation with the degree of hemolysis of the serum samples. Anti-Toxoplasma gondii antibodynegative samples, separated by subjective groupings based on degree of hemolysis, into "clear," "slight," and "gross/total" samples, had a mean ± standard deviation of 0.150 ± 0.072, 0.187 ± 0.105, and 0.232 ± 0.108, respectively. The incorporation of sodium azide during the initial step of serum dilution dramatically eliminated the background, giving a mean ± standard deviation of 0.079 ± 0.029, 0.076 ± 0.022, and 0.081 ± 0.029, respectively. The level of endogenous peroxidase activity, a possible factor for this nonspecific interference, was considerably elevated in some of the swine sera. The clear, slight, and gross/total categories had relative levels of 1%, 2%, and 51% peroxidase activity compared to the conjugate peroxidase activity of 100%. Whereas sodium azide could be used only in sample predilution in the swine toxoplasmosis peroxidase-conjugate test, in the bovine brucellosis alkaline phosphatase-conjugate card test it could be used in all wash cycles. Many brucellosis card test results were visually uninterpretable because of significant background color when the manufacturer's wash reagent was used. The substitution of a wash reagent containing sodium azide eliminated background color, giving a visually unambiguous test.
The enzyme immunoassay (EIA) was introduced in 1971 6, 23 and is now the most widely used testing methodology worldwide.
1 Two of the most widely used enzyme conjugates in EIA methodologies are peroxidase (PO) and alkaline phosphatase (AP). However, these enzymes are also present in normal body tissues and fluids. 14, 17, 19, 21 These endogenous enzymes thus are a potential source of nonspecific color development. In a homogeneous EIA both the immunological reaction and the detection of the extent of the reaction are carried out in a homogeneous solution without physical separation of free and antibody-bound components. The problem of interference by endogenous enzymes is well recognized and enzyme markers such as ß-galactosidase and glucose oxidase, being absent endogenously, are used. 22 In a heterogeneous EIA, such as reported here, nonspecific color development resulting from the presence of endogenous enzymes has not been considered to be a serious problem because of the wash cycles between each incubation step. Unlike homogeneous EIAs, all heterogeneous assays have at least 1 separation step that differentiates reacted from unreacted materia1. Received for publication April 7, 1994. In a previous study this laboratory reported that extensively hemolyzed serum samples adversely affected EIA test results in a methodology using PO conjugate. 2 It was speculated that the interference was caused by PO from white blood cells. The background color could be eliminated by the addition of sodium azide to the sample prior to being assayed.
In this article we report our experience in solving substantial background-color problems encountered in dealing with slightly to extensively hemolyzed serum samples in assays using PO conjugate (detection of swine anti-Toxoplasma antibodies using a microtiter EIA procedure) and AP conjugate (detection of bovine anti-Brucella antibodies using an onsite rapid card test kit).
Materials and methods

Toxoplasmosis enzyme immunoassay
Antigen. Trophozoites of Toxoplasma gondii a (cell cultured, unfixed strain RH) with 2 x 10 9 organisms per ml were centrifuged at 2,000 x g for 15 min after disruption by freeze-thawing. The supematant, with a protein concentration of 3.3 mg/ml, was used as stock antigen and was stored at -50 C.
Assay. An EIA was developed to detect anti-T. gondii immunoglobulin G antibody in swine serum samples. 6 Tests were conducted in microtiter plates b with flat-bottom wells. Plates were coated with 100 µl stock antigen diluted 1:400 in 0.03 M sodium bicarbonate buffer, pH 9.6, with 0.02% Between incubation periods wells were washed six times with phosphate-buffered saline, pH 7.4, containing 0.05% Tween 80 d (PBST). To establish the role of sodium azide in reducing nonspecific color development, each serum sample was divided into 2 aliquots. One aliquot was diluted 1:100 with PBST (untreated) and the other was diluted 1:100 with PBST containing 0.1% sodium azide (PBSTZ) (treated). Forty samples, in duplicate, plus 3 controls and a blank (4 wells each) were tested in a single plate with sample placement to minimize well-position effect.
20 Anti-porcine IgG peroxidase conjugate e was diluted 1:1,000 in PBST. The substrate solution was H 2 O 2 and ABTS f diluted in distilled water. The substrate reaction was stopped after 5 min incubation. Optical density (OD) was measured at 405 nm.
Serum samples. A total of 799 serum samples from 1 mo of a 12-mo national survey for swine pseudorabies seroprevalence was used. 4 The samples, when originally received and stored in our serum bank, had been classified subjectively into 4 groups based on degree of hemolysis: clear (no hemolysis), slight (tinge to light red), gross (slight to dark red), and total (almost black).
Two hundred of the serum samples, anti-Toxoplasma antibody negative by a modified agglutination test (MAT) at a dilution of 1:25 were used to develop the positive/negative threshold for the toxoplasmosis enzyme immunoassay 4,5 and to conduct further analyses in the evaluation of the effect of sodium azide in reducing nonspecific color development.
A second subgroup of 90 serum samples were anti-T. gondii positive by the reported EIA, based on the threshold established in the analyses of the 200 MAT antibody-negative sera.
Measurement of endogenous PO activity. Endogenous PO
was demonstrated and its activity was measured by adding substrate directly to diluted serum aliquots from pooled untreated samples representing clear, slight, and combined gross/ 
Brucellosis card test
Brucellosis. Recently developed card tests for brucellosis h were used for the detection of anti-Brucella antibodies in cattle serum samples. The test procedure was that of the manufacturer, using the AP conjugate and other reagents provided with the kit. In the comparative study to determine the effect of sodium azide, serum samples were tested undiluted and were not pretreated with sodium azide. Tests were run simultaneously on 2 aliquots of each serum sample. The wash reagent used for 1 aliquot was that supplied with the test kit (untreated) and for the second aliquot was PBSTZ (treated . Relative PO activity in untreated clear, slight, and gross/total sera compared with the anti-porcine conjugate used during the actual assay procedure set at 100% activity. Calculated rel- Figure 3 . PO activity in clear, slight, and gross/total serum sam-ative PO activity is based on sample and reagent dilutions used in ples and anti-porcine conjugate measured over time at 1:100, 1:200, the assay (serum, 1:100; conjugate, 1:1,000). 1:1,000, and 1:20,000 dilutions, respectively. All dilutions were made with PBST. Calculated units of PO activity are per ml of undiluted sample. ment. One sample in this group showed a 29% increase in OD after treatment. samples negative for anti-T. gondii antibody, the group of untreated aliquots had an OD mean ± standard Endogenous PO activity deviation of 0.194 ± 0.105 (OD range of 0.032-0.66 1). The treated aliquots had an OD mean ± standard deviation of 0.078 ± 0.025 (OD range of 0.017-0.153). The EIA analyses of treated and untreated aliquots of the three hemolytic categories are shown in Fig. 1 . The mean OD readings of the untreated aliquots (no sodium azide) show a direct correlation with the degree of hemolysis. The treated aliquots, however, show virtually identical mean OD readings.
In the comparison of untreated and treated aliquots of the 90 serum samples positive for anti-T. gondii antibody, the group of untreated aliquots had an OD mean ± standard deviation of 0.274 ± 0.145 (OD range of 0.078-0.640), whereas the treated aliquots showed less variation, with an OD mean ± standard deviation of 0.224 ± 0.116 (OD range of 0.142-0.824). The EIA analyses of treated and untreated aliquots of the three hemolytic categories are shown in Fig. 2 . As was evident with the negative samples, the untreated aliquots of the positive samples showed progressively higher ODs that correlated with the degree of hemolysis.
Compared to the negative samples, the percent reduction in enzyme activity in the treated aliquots of the positive samples is much less, 19% vs. 60%. The average of 60% reduction in enzyme activity in the negative samples after PBSTZ treatment is composed of 47%, 59%, and 65% in the clear, slight, and gross/ total categories, respectively. In the positive samples, however, the average of 19% reduction in EIA activity after treatment is broken down to 8% and 45% in the slight and gross/total categories, respectively, whereas the clear category showed an increase of 6% after treat-PO activity measured separately in the pooled clear, slight, and gross/total hemolytic serum categories and in anti-porcine conjugate is shown in Fig. 3 for untreated samples. PO activity in treated aliquots is not indicated as OD readings were less than those for untreated aliquots at 1 minute incubation and remained at essentially the same level throughout the 30-minute evaluation period. Figure 4 shows the relative endogenous PO activity in pools of each of the serum hemolytic categories when diluted 1:100 in PBST (untreated), the routine test dilution, compared to conjugate PO activity (equals 100%) when diluted 1:1,000 in PBST, the routine test dilution.
When the manufacturer's protocol was followed, color differences between a test reaction and its respective sample control were visually indistinguishable in many of the untreated samples, whether anti-Brucella antibody negative or positive.
For anti-Brucella antibody-negative sera (Table 1) , the control and test reactions of the untreated aliquots were not significantly different (P = 0.4651) nor were they visually distinguishable. The same was true for the treated aliquots (P = 0.5051). However, the mean delta-E values of the treated aliquots were significantly different than those of the untreated aliquots, both for the control (P = 0.0001) and the test reactions (P = 0.0001).
For anti-Brucella antibody-positive sera (Table 2) , the control and test reactions of the untreated aliquots were not significantly different (P = 0.1760) and were visually indistinguishable. However, in the treated ali- † Absolute average difference.
quots, the control and test reactions were significantly different (P = 0.0001) and were visually unambiguous. effective in eliminating an extensive background prob-
Discussion
lem, especially in hemolyzed samples. If added to any of the "wash" steps, sodium azide inactivated the conOne of the significant causes of background color development in heterogenous enzyme immunoassays is the nonspecific attachment of residual conjugates at nonantigenic sites on the adsorbed protein and/or directly on the solid-phase surface.
The extreme sensitivity of EIA technology is due to the high turnover of enzyme-labeled antibodies (conjugates). A single enzyme molecule can typically convert 10 3 -10 6 molecules of substrate into products. 9 On the negative side, however, it will also amplify nonspecific reactions. In this study PBSTZ was crucial to the elimination of the nonspecific interference present in the test samples.
Blood PO, present primarily in leukocytes, is one of the richest sources of PO activity, 3, 7, 8 with some authors reporting its concentration to the extent of 5% of the entire dry weight of the blood. 18 Endogenous PO, if immobilized on the solid-phase surface and/or on preadsorbed proteins, could contribute significantly to nonspecific color development as only 0.0075% PO is required to catalyze a reaction. 8 A previous study in this laboratory showed that preassay treatment of hemolyzed sera with sodium azide would eliminate the nonspecific reactions that were speculated to be caused by endogenous peroxidase.
2 However, the effect of the treatment by sodium azide over a range of hemolysis and specific analyte concentrations was not undertaken.
Sodium azide is a potent inhibitor of PO. 12, 13 It is reported to inhibit catalytic PO activity irreversibly 11 and would, therefore, render endogenous PO catalytically inactive during preassay serum dilution with PBSTZ. We have shown that the simple step of prediluting serum samples with sodium azide was very jugate PO.
Although this study utilized different degrees of hemolysis to separate and evaluate serum samples for their varying contributions to nonspecific color development in the respective enzyme immunoassays, the hemolysis acted only as a guide, and apparently a good guide, to the potential damage done to other cellular components of the blood.
The PO activity in untreated samples was demonstrated and was significant, especially in the gross/total hemolytic category (Fig. 3) . In this group endogenous PO activity equaled that of the conjugate PO when both were diluted to routine test parameters (Fig. 4) . It is quite likely that 1 or more of the individual samples in the pool had endogenous peroxidase activity equal to or greater than that normally present in the working dilution of the conjugate.
In this report the demonstration of the magnitude of reduction in OD in the treated aliquots of the different hemolytic sample categories (Figs. 1, 2) depended upon at least 3 primary factors: both the amount of specific anti-Toxoplasma antibody and endogenous enzyme in the test sample and the substrate incubation time interval (5 minutes) when test results were recorded. There may be other factors involved as some of the treated antibody-positive samples showed increased ODs after treatment.
When the ODs of the 200 anti-Toxoplasma antibody negative samples diluted with PBSTZ (treated) are matched with a corresponding aliquot diluted with PBST (untreated), regardless of hemolytic category the absence of specific anti-Toxoplasma antibody is clearly demonstrated by the early reaction rate differences between the treated-and untreated-aliquot substrate re-actions at 5 minutes incubation. In each of the hemolytic categories the differences were statistically significant at this incubation time (Fig. 1) . The mean OD of all aliquots of the sodium azide-treated samples (0.078) was less than V-2 that of the combined untreated samples (0.194), with P < 0.0001. There was a direct correlation between OD readings in the untreated samples and the hemolytic category groups.
When the 5-minute substrate incubation ODs of the group of 90 anti-Toxoplasma antibody-positive samples are matched before and after sodium azide treatment, the reaction rate differences in the clear and slight hemolytic categories are not significantly different at a 5-minute substrate incubation (Fig. 2) . The presence of specific anti-Toxoplasma antibody in these samples significantly increases the reaction rates over those seen in the respective antibody-negative samples. Further, in these samples the endogenous PO is only a small percentage when compared to the test PO itself, and the reaction rates of the treated and untreated aliquots are, therefore, similar in the shorter incubation period. However, in the gross/total hemolytic category, the endogenous PO is much greater and significantly increases the reaction rate, which is distinctly discernible even at the 5-minute substrate incubation interval (Fig. 2) .
Although the sodium azide had a definite effect on the test result, from the overall study it appears that specific antigen/antibody interaction is not adversely affected by the sodium azide treatment used in this study.
Unlike in the toxoplasmosis enzyme immunoassay, sodium azide could be used in all wash cycles of the bovine brucellosis card test. APs, present ubiquitously in body tissues and fluids in high concentration, [14] [15] [16] are a family of enzymes with a wide range of characteristics. Intestinal AP is uniquely discerned from nonintestinal APs. Our results corroborate that sodium azide has little or no effect on conjugate AP 23 (which is specified to be intestinal AP in most commercial preparations).
However, it appears that sodium azide inhibits endogenous nonintestinal AP. We substituted levamisole, which preferentially inhibits nonintestinal AP, 10 in lieu of PBSTZ in the wash reagent, with equal reduction in nonspecific color development. It is possible that sodium azide, in relation to AP, functions similar to levamisole, having no effect on conjugate AP, but inhibiting endogenous nonintestinal AP, which we believe was a primary contributor to the nonspecific background color of the brucellosis card test.
The results of a test system targeted for field use as a screening tool must be as unambiguous as possible. Too often users of a field test are required to make judgements based on evaluations of ambiguous test results. With the brucellosis card test used in the studies reported here, after a 5-minute substrate incubation, there was no visually distinguishable color in any of the treated-control reactions nor in the treated antibody-negative test reactions. In treated antibodypositive test reactions, color development was generally readily visible within 15 seconds of the addition of substrate. Hemolyzed samples did not interfere with test result evaluations because the majority of the initial sample color was restricted from the reaction area of the card during lateral flow of the serum sample through a membrane. In the few cases when a tinge of color reached the reaction area, the successive wash cycles cleared it out.
In our test development procedures, but for the use of sodium azide, the two test systems reported here would have been discarded due to excessive nonspecific color development.
